Published in Scand J Gastroenterol on December 01, 1986
Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev (1989) 3.67
Incidence of Crohn's disease in Stockholm County 1955-1989. Gut (1997) 1.52
Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing? World J Gastroenterol (2008) 1.21
Disability from inflammatory bowel disease among employees in West Germany. Gut (1989) 1.05
The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol (2012) 0.98
Crohns disease in Slovakia: prevalence, socioeconomic and psychological analysis. Eur J Epidemiol (1998) 0.79
Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int (1998) 2.60
A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med (1994) 2.58
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology (1991) 1.93
Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol (2003) 1.70
Walking training of patients with hemiparesis at an early stage after stroke: a comparison of walking training on a treadmill with body weight support and walking training on the ground. Clin Rehabil (2001) 1.69
Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol (2001) 1.64
Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut (2000) 1.60
Features of Sjögren's syndrome in patients with primary biliary cirrhosis. J Intern Med (1991) 1.58
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology (1996) 1.58
Spatial properties of nutrient concentrations in the Baltic Sea. Environ Monit Assess (1995) 1.50
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Aliment Pharmacol Ther (2012) 1.49
In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health (1993) 1.47
Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med (1994) 1.39
[Different anamnestic approaches in the treatment of dyspepsia. Quicker access to gastroscopy should make the diagnosis easier]. Lakartidningen (2000) 1.38
Adenosine triphosphate levels of mammalian pancreatic B cells after stimulation with glucose and hypoglycemic sulfonylureas. Diabetes (1969) 1.36
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol (1995) 1.36
beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol (2004) 1.35
Colonic endocrine cells in inflammatory bowel disease. J Intern Med (1997) 1.35
A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis (1997) 1.33
Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol (1996) 1.31
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol (2003) 1.31
Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment. Gastroenterology (1983) 1.26
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut (1996) 1.25
Pulmonary function in adolescent idiopathic scoliosis: a 25 year follow up after surgery or start of brace treatment. Thorax (2001) 1.20
Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther (1994) 1.14
Studies on the active site of deacetoxycephalosporin C synthase. J Mol Biol (1999) 1.13
Techniques for measuring amylase secretion from pieces of mouse pancreas. Anal Biochem (1974) 1.12
Kidney effects in long term exposed lead smelter workers. Br J Ind Med (1992) 1.11
Acute liver failure in Sweden: etiology and outcome. J Intern Med (2007) 1.11
The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies. Eur J Biochem (1978) 1.11
Colchicine treatment of primary sclerosing cholangitis. Gastroenterology (1995) 1.07
Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones. Gut (1990) 1.07
Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med (2003) 1.05
Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int (1998) 1.05
Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther (1993) 1.04
Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol (1988) 1.01
Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem (1986) 1.01
Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol (1997) 1.00
Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J Biol Chem (1987) 1.00
Gastrointestinal symptoms in myotonic dystrophy. Scand J Gastroenterol (1996) 0.99
Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology (1994) 0.97
Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy. Scand J Gastroenterol (1992) 0.95
Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol (2008) 0.95
Binding to antithrombin of heparin fractions with different molecular weights. Biochem J (1981) 0.94
A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol (1999) 0.93
Muscle and tendon stiffness in patients with upper motor neuron lesion following a stroke. Eur J Appl Physiol (2000) 0.92
Prevalence of Back Problems in 1069 Adults With Idiopathic Scoliosis and 158 Adults Without Scoliosis. Spine (Phila Pa 1976) (2014) 0.92
No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterol Motil (2007) 0.91
Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features. Hepatogastroenterology (1999) 0.90
Beeturia and colonic oxalic acid. QJM (1995) 0.90
Eating a meal increases the clearance of ethanol given by intravenous infusion. Alcohol Alcohol (1994) 0.90
Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. Eur J Clin Pharmacol (1981) 0.89
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens (2002) 0.89
Aggravation of thiamine deficiency by magnesium depletion. A case report. Acta Med Scand (1985) 0.88
Effects of alpha- and beta-receptor blocking agents on catecholamine and 5-hydroxytryptamine induced peroxidase and amylase secretion from guinea pig submandibular gland. Acta Physiol Scand (1974) 0.88
The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther (2010) 0.88
Chronic colitis induces expression of β-defensins in murine intestinal epithelial cells. Clin Exp Immunol (2010) 0.88
Protective effect of S-adenosyl-L-methionine on bromobenzene- and D-galactosamine-induced toxicity to isolated rat hepatocytes. Hepatology (1996) 0.87
The site in human antithrombin for functional proteolytic cleavage by human thrombin. FEBS Lett (1981) 0.87
Characterization of the rat parotid beta-adrenoceptor. Br J Pharmacol (1981) 0.87
Toxicity of hepatotoxins: new insights into mechanisms and therapy. Expert Opin Investig Drugs (1999) 0.86
Studies on parotid saliva in cystic fibrosis. Acta Paediatr Scand (1982) 0.86
The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine. Ann Clin Res (1980) 0.86
Alkaline phosphatase isozymes in non-malignant intestinal and hepatic diseases. Scand J Gastroenterol (1988) 0.86
Dopamine-induced amylase secretion from guinea-pig submandibular gland. Br J Pharmacol (1975) 0.86
Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates. Scand J Gastroenterol (1994) 0.86
Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease. Neurogastroenterol Motil (2013) 0.85
Levels of -ketoglutarate and glutamate in stimulated pancreatic -cells. Horm Metab Res (1970) 0.85
Magnesium in Crohn's disease. Acta Med Scand Suppl (1982) 0.85
Spectral analysis of heart rate variability in patients with irritable bowel syndrome. Scand J Gastroenterol (1998) 0.84
Neuroendocrine changes in colon of mice with a disrupted IL-2 gene. Clin Exp Immunol (2000) 0.84
Fractionated irradiation and early changes in salivary glands. Different effects on potassium efflux, exocytotic amylase release and gland morphology. Lab Invest (1991) 0.84
Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig Dis Sci (1996) 0.84
Vagal regulation of the gastrointestinal neuroendocrine system. Scand J Gastroenterol (1996) 0.83
Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function. Hepatogastroenterology (1984) 0.83
Steroid and thyroid hormones modulate a changing brain. J Steroid Biochem Mol Biol (1991) 0.83
Secretory behavior and ultrastructural changes in mouse gallbladder principal cells after stimulation with cholinergic and adrenergic drugs. A morphometric study. Gastroenterology (1979) 0.83
An adaptation of hydrophobic interaction chromatography for estimation of protein solubility optima. J Pharm Biomed Anal (1997) 0.83
Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut (1991) 0.83
Simultaneous release of amylase and peroxidase from the guinea pig submandibular gland. FEBS Lett (1972) 0.83
Clinical trial: the safety and short-term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn's disease. Aliment Pharmacol Ther (2009) 0.83
Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy. Eur J Gastroenterol Hepatol (2001) 0.83
Dynamics of beta adrenoceptor induced amylase release and cyclic AMP accumulation in the guinea pig submandibular gland. Acta Physiol Scand (1979) 0.82
Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin. Biochem J (1983) 0.82
Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand J Gastroenterol (2000) 0.82
Effects of starvation and islet hormones on the synthesis of amylase in isolated exocrine pancreas of the mouse. Acta Hepatogastroenterol (Stuttg) (1974) 0.81
Bile acid malabsorption after intestinal bypass surgery for obesity. A comparison between jejunoileal shunt and biliointestinal bypass. Int J Obes (1990) 0.81
Effects of unilateral cervical vagotomy on antral endocrine cells in mouse. Histol Histopathol (1999) 0.81
Mechanisms of diarrhoea in myotonic dystrophy. Eur J Gastroenterol Hepatol (1998) 0.81
Nutritional aspects in patients with functional gastrointestinal disorders and motor dysfunction in the gut. Working team report of the Swedish Motility Group (SMoG). Dig Liver Dis (2007) 0.81
Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid. Gut (1988) 0.81
Mechanism of inactivation of trypsin by antithrombin. Biochem J (1982) 0.80
Blood pressure changes in man during infrasonic exposure. An experimental study. Acta Med Scand (1985) 0.80
Effect of cholecystokinin-pancreozymin (CCK-PZ) on glycoprotein secretion from mouse gallbladder epithelium: an ultrastructural and cytochemical study. Cell Tissue Res (1976) 0.80
Quantitative structural analysis and the secretory behaviour of the rat parotid gland after long and short term isoprenaline treatment. Med Biol (1979) 0.80
Effects of a new selective beta1-adrenoceptor agonist on amylase secretion from the rat parotid gland. Br J Pharmacol (1978) 0.80